Delivery Order SPE2DB20D3103-SPE2DB24FQ0Z5

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $37K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,123.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is a Delivery Order for Firm Fixed Price procurement of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and there is no set-aside designation for this award. The contract is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,444.07, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of July 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,181.40 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen is the prime contractor, and there is no set-aside designation indicated. This contract is part of a larger...
This federal contract award, valued at $14,722.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, with an ultimate completion date of June 17, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award does not have a set-aside designation, indicating open...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,659.73 delivery order contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of December 27, 2024 and is a firm fixed-price contract type. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, valued at $47,919.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, with a performance period ending on January 13, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. The contract was not designated with a set-aside requirement,...
This federal contract award, valued at $29,526.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a period of performance ending on May 8, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $19,349.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a completion date of December 17, 2024. The contract is a Delivery Order under a Firm Fixed Price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,134.80 firm fixed-price delivery order contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S medication. The contract has an ultimate completion date of April 3, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $1,282.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a period of performance through June 21, 2024. The contract was not designated with a set-aside requirement, indicating open competition....
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FQ0Z5
    Delivery Order

This federal contract award, valued at $36,665.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. The contract is a firm fixed-price delivery order with an ultimate completion date of August 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this contract as part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/28/24, 9:02 AM